MYGN Myriad Genetics
- 16.280
- +0.110+0.68%
- 16.280
- 0.0000.00%
Myriad Genetics News
Myriad Genetics | 8-K: Current report
Myriad Genetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GLENVIEW CAPITAL MANAGEMENT, LLC(1.39%),LARRY ROBBINS(1.39%)
Myriad Genetics | 10-Q: Q3 2024 Earnings Report
Myriad Genetics | 8-K: Current report
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer DIAZ PAUL J
Myriad Genetics | 144: Notice of proposed sale of securities pursuant to Rule 144
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Verratti Mark
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Muzzey Dale
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Haas Kevin Richard
Myriad Genetics | 8-K: Current report
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Verratti Mark
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Ancona Margaret
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Munk Natalie
Myriad Genetics | 144: Notice of proposed sale of securities pursuant to Rule 144
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer DIAZ PAUL J
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Muzzey Dale
Myriad Genetics | 144: Notice of proposed sale of securities pursuant to Rule 144
Myriad Genetics | 144: Notice of proposed sale of securities pursuant to Rule 144
Myriad Genetics | 4: Statement of changes in beneficial ownership of securities-Director Dreismann Heinrich
Myriad Genetics | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
No Data